Showing results (131-140 of 235) with videos related to
Sort By:
Pageof 24
The Lancet. Oncology|September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trialLi-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202Amin J Mirhadi, Qiang Zhang, Gerald E Hanks, et al.International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapyMary Feng, Alexandra L Hanlon, Thomas M Pisansky, et al.Cancer|March 22, 2017
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621Mark D Hurwitz, Jonathan Harris, Oliver Sartor, et al.International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experienceDaniel A Hamstra, Anna S C Conlon, Stephanie Daignault, et al.European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.Cancer|April 8, 2015
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trialDeborah W Bruner, Daniel Hunt, Jeff M Michalski, et al.International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.Pageof 24